Patent Assignment
Reel/Frame 015043/0366
Merger and Change of Name
Recorded: 2004-03-08
Pages: 4
Assignor
BTG PHARMACEUTICALS CORP.
Executed: 1996-03-14
Assignee
BIO-TECHNOLOGY GENERAL CORP.
700 WOOD AVENUE SOUTH 2ND FLOOR, ISELIN, NEW JERSEY, 08830
Covered Property
(1)
Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1
Application:
10/052,961 →
Publication:
US 2002/0091155
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Jan 16, 2004
From: BIO-TECHNOLOGY GENERAL CORP.
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 014871/0808 →
Change of Name
Jun 21, 2004
From: BIO-TECHNOLOGY GENERAL CORP.
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 014754/0469 →
Security Agreement
Jun 12, 2012
From: SAVIENT PHARMACEUTICALS, INC.
To: MORGAN STANLEY SENIOR FUNDING INC.
Reel/Frame 028363/0040 →
Corrective Assignment to Correct the Receiving Party Previously Recorded on Reel 028363 Frame 0040. Assignor(S) Hereby Confirms the Security Agreement.
Jul 23, 2013
From: SAVIENT PHARMACEUTICALS, INC.
To: U.S. NATIONAL BANK ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 030936/0072 →